260 related articles for article (PubMed ID: 15893636)
1. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration.
Diaz-Corrales FJ; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N
Neuroscience; 2005; 133(1):117-35. PubMed ID: 15893636
[TBL] [Abstract][Full Text] [Related]
2. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
3. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Höglinger GU; Lannuzel A; Khondiker ME; Michel PP; Duyckaerts C; Féger J; Champy P; Prigent A; Medja F; Lombes A; Oertel WH; Ruberg M; Hirsch EC
J Neurochem; 2005 Nov; 95(4):930-9. PubMed ID: 16219024
[TBL] [Abstract][Full Text] [Related]
5. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
8. Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction.
Surguchov A; Palazzo RE; Surgucheva I
Cell Motil Cytoskeleton; 2001 Aug; 49(4):218-28. PubMed ID: 11746666
[TBL] [Abstract][Full Text] [Related]
9. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
Leng A; Feldon J; Ferger B
Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
[TBL] [Abstract][Full Text] [Related]
11. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
13. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein.
Lee HJ; Khoshaghideh F; Lee S; Lee SJ
Eur J Neurosci; 2006 Dec; 24(11):3153-62. PubMed ID: 17156376
[TBL] [Abstract][Full Text] [Related]
14. Function of donor cell centrosome in intraspecies and interspecies nuclear transfer embryos.
Zhong ZS; Zhang G; Meng XQ; Zhang YL; Chen DY; Schatten H; Sun QY
Exp Cell Res; 2005 May; 306(1):35-46. PubMed ID: 15878330
[TBL] [Abstract][Full Text] [Related]
15. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.
Phinney AL; Andringa G; Bol JG; Wolters ECh; van Muiswinkel FL; van Dam AM; Drukarch B
Parkinsonism Relat Disord; 2006 May; 12(4):228-38. PubMed ID: 16488175
[TBL] [Abstract][Full Text] [Related]
16. Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry.
Mirzaei H; Schieler JL; Rochet JC; Regnier F
Anal Chem; 2006 Apr; 78(7):2422-31. PubMed ID: 16579629
[TBL] [Abstract][Full Text] [Related]
17. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
18. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
19. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
Saravanan KS; Sindhu KM; Mohanakumar KP
Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
[TBL] [Abstract][Full Text] [Related]
20. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.
Zhou Y; Shie FS; Piccardo P; Montine TJ; Zhang J
Neuroscience; 2004; 128(2):281-91. PubMed ID: 15350641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
